Microbot Stock Gains On Successful GLP Pivotal Pre-Clinical Study Results
Microbot Medical Inc. (MBOT), a pre-clinical medical device company, gained 47% after announcement of positive results from its GLP pivotal pre-clinical study of Liberty Endovascular Robotic Surgical system.
Source: rttnews.com